Treatment of ocular hypertension with a synergistic combination

Details Treatment of ocular hypertension with a synergistic combination Treatment of ocular hypertension with a synergistic combination

1995-06-07

1996-08-20

Fay, Zohreh

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514530, 514573, 514913, A61K 3141, A61K 31215, A61K 3119

Patent

active

055479685

ABSTRACT:
A method for treatment of ocular hypertension which comprises ocularly administering, to a subject in need of such treatment, an oculo-hypotensively synergistic combination of

REFERENCES:
patent: 5001153 (1991-03-01), Ueno et al.
Embase, embase No. 89199131; M. F. Sugrue: "The pharmacology of antiglaucoma drugs", & Pharmacol. Ther., 1989, 43/1 (91-138).
Embase, embase no. 82085670; M. Beausang-Linder: "Effects of sympathetic stimulation on cerebral and ocular blood flow. Modification by hypertension, hypercapnia, acetazolamide, PGIsub 2 and papaverine", & Acta Physiol. Scand., 1982, 114/2 (217-224).
J. Pharmacol. Exp. Ther. (USA), 1985, 232/2 (534-540) Sugrue et al. (See the Embase abstract).

Affiliated with

Also associated with

Rating

Treatment of ocular hypertension with a synergistic combination does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of ocular hypertension with a synergistic combination, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of ocular hypertension with a synergistic combination will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2330988